Medicine and Dentistry
Cost-Effectiveness Analysis
100%
Pediatric Surgery
75%
Health Care
75%
Technology Assessment
75%
Medical Technology
50%
Newborn Surgery
50%
Laboratory Test
25%
Congenital Malformation
25%
Effectiveness Study
25%
Interdisciplinary Care
25%
Neonatal Infant
25%
Health Technology
25%
Doctor of Philosophy
25%
General Practitioner
25%
Patient Safety
25%
Nursing and Health Professions
Cost Effectiveness Analysis
100%
Pediatric Surgery
75%
Health Care
75%
Health Care Policy
50%
Medical Technology
50%
Health Care Management
50%
Biomedical Technology Assessment
25%
Pediatric Hospital
25%
General Practitioner
25%
Patient Safety
25%
Doctor of Philosophy
25%
Interdisciplinary Care
25%
Laboratory Test
25%
Congenital Malformation
25%
Pharmacology, Toxicology and Pharmaceutical Science
Biosimilar Agent
100%
Crohn's Disease
100%
Infliximab
100%
Randomized Clinical Trial
100%
Remission
33%
Azathioprine
11%
Biological Product
11%
Randomized Controlled Trial
11%
Disease Activity
11%
Treatment Group
11%